Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Paul Perona

Orthopaedic Surgery Ottawa, IL Medical Doctor

NPI 1558476010 CMS profile 206185

1306 Gemini Cir Ste 2, Ottawa, IL 61350

Open in the dashboard

General payments

$121,983

131 records reported · program years 2019–2025

Research payments

$109,233

Paid to them · 35 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$19,059 paid to institutions, not to them · program years 2019–2022

Through program year 2025, Paul Perona of Ottawa, IL is reported in the CMS Open Payments database as having received $121,983 across 131 general payments and $109,233 in research payments paid to them. Separately, studies naming them as principal investigator received $19,059 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

14 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $206 5
2025 Research $4,560 1
2024 General $12,351 8
2024 Research $5,213 2
2023 General $43,568 45
2023 Research $17,116 6
2022 General $9,613 9
2022 Research $11,490 6
2021 General $21,989 16
2021 Research $19,720 5
2020 General $1,906 10
2020 Research $21,600 8
2019 General $32,349 38
2019 Research $29,535 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Paul Perona
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Paul Perona were reported at $206. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Paul Perona Orthopaedic Surgery median Middle half National median
2019 $32,349 $644 $140–$2,844 $163
2020 $1,906 $312 $75–$1,860 $114
2021 $21,989 $520 $117–$2,495 $132
2022 $9,613 $598 $128–$2,731 $149
2023 $43,568 $461 $128–$2,264 $160
2024 $12,351 $497 $134–$2,475 $164
2025 $206 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $121,798 123 payments
  2. DePuy Synthes Sales Inc. $100 4 payments
  3. Pacira Pharmaceuticals Incorporated $25 1 payment
  4. Janssen Biotech, Inc. $23 1 payment
  5. Heron Therapeutics, Inc. $20 1 payment
  6. Medline Industries, Inc. $17 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $96,064 18 payments
  2. Travel and Lodging $23,262 48 payments
  3. Food and Beverage $2,657 65 payments
Products named General payments · program years 2019–2025
  1. MAKO Knees, Hips $76,643 49 payments
  2. MAKO Knees, Hips $22,312 31 payments
  3. TRIATHLON Knees $12,897 17 payments
  4. TRIATHLON Knees $9,628 4 payments
  5. NEW PRODUCT DEVELOPMENT $2,004 9 payments
  6. SECUR-FIT $264 1 payment
  7. DYNACORD $66 1 payment
  8. ACCOLADE Hips $35 1 payment
  9. TORNIER PERFORM REVERSED GLENOID $35 1 payment
  10. ACCOLADE Hips $25 1 payment
  11. Other $119 7 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Stryker Corporation $109,233 35 payments

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

25

Median for Orthopedic Surgery: 203

Drug cost

$15

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amoxicillin Generic 25 $15

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 100 billing codes

Paid by Medicare

$272,377

Of which drugs: $1,215

Medicare patients

651

Average age 75

Services billed

2,236

396 women, 255 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 26%
Ischemic heart disease 23%
Chronic kidney disease 21%
Depression 20%
Atrial fibrillation 19%
COPD 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 59 262 $887

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

166 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record